![Zhen Su](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Zhen Su is currently Chief Executive Officer & Director at Marengo Therapeutics, Inc. since 2021, Independent Director at Karyopharm Therapeutics, Inc. since 2023, and Independent Director at CytomX Therapeutics, Inc. since 2024.
Former roles include SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021, Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019, and Director-Cell & Gene Therapy Program at the University of Florida from 2006 to 2009.
Education includes an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 30/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Miembro de la Junta | 31/08/2023 |
| CYTOMX THERAPEUTICS, INC. | Director/Miembro de la Junta | 21/03/2024 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Director Ejecutivo | 01/07/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK KGAA | Director Técnico/Científico/I+D | 01/01/2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Director Técnico/Científico/I+D | 01/01/2019 |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Dresden University of Technology
 Dresden University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
